tci Part B Insider - 2003 Issue 9

COMPLIANCE: Drugmaker Guidance Could Have Wide Reach to Physicians

If you're accepting free services or payments as an inducement to prescribe a particular drug, you could be writing a prescription for disaster. The HHS Office of Inspector General's compliance guidance for pharmaceutical companies, released April 23, has important lessons for both pharmacies and other providers, experts say. The OIG casts such a broad net for fraud and abuse that the drugmaker-tailored guidance should raise red flags for providers of all stripes. The final CPG is far more detailed than the draft version issued last October. Here are the hot spots in a nutshell: Data Integrity. Drugmakers face False...

To read the full article, sign in and subscribe to tci Part B Insider.


Keep pace with evolving Medicare regulations with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI’s Part B Insider will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4800 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.